Navigation Links
New polymer could improve semiconductor manufacturing, packaging
Date:1/28/2008

Troy, N.Y. Researchers at Rensselaer Polytechnic Institute and Polyset Company have developed a new inexpensive, quick-drying polymer that could lead to dramatic cost savings and efficiency gains in semiconductor manufacturing and computer chip packaging.

Along with allowing enhanced performance and cost savings for conventional photolithography processes, the new material, called polyset epoxy siloxane (PES), should also enable a new generation of lower-cost, on-chip nanoimprinting lithography technology, according to the researchers.

With this new material, chip manufacturers will be able to trim several steps from their production and packaging processes, and in turn realize a cost savings, said Toh-Ming Lu, the R.P. Baker Distinguished Professor of Physics at Rensselaer, who oversaw the study. PES is cheaper and more reliable.

Lus research was published this week in the Journal of Vacuum Science and Technology B.

The widely adopted technique of photolithography involves using a mix of light and chemicals to generate intricate micro- and nano-scale patterns on tiny areas of silicon. As part of the process, a thin polymer film called a redistribution layer, and crucial to the effectiveness of device is deposited onto the silicon wafer, in order to ease the signal propagation delay and to protect the chip from different environmental and mechanical factors.

The new PES material developed by Lus group and Polyset Company is one such thin polymer film, and it offers several advantages over the incumbent materials typically used in the semiconductor manufacturing industry. In addition, their new PES material can also be used as a thin polymer film for ultraviolet (UV) on-chip nanoimprinting lithography technology, which is still in the early phases of development. The consistency of using PES in conventional technology, and then continuing to use PES while academia and industry test and graduall
'/>"/>

Contact: Michael Mullaney
mullam@rpi.edu
518-276-6161
Rensselaer Polytechnic Institute
Source:Eurekalert  

Page: 1 2

Related biology technology :

1. NIST team develops novel method for nanostructured polymer thin films
2. AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000
3. Hybrid semiconductors show zero thermal expansion; Could lead to hardier electronics
4. Multigene Test Predicts Who Could Avoid Chemotherapy Despite Positive Lymph Nodes in Early Breast Cancer
5. DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program
6. Tethered to chip, energy supply that drives sperm could power nanobot
7. ORNL super water repellent could cause big wave in market
8. Blue dye could hold the key to super processing power
9. FED-TVs with carbon nanotube technology could supersede plasma and LCD flat screens
10. Stem Cell Breakthrough Could End Human Embryonic Experimentation
11. Bone-growing nanomaterial could improve orthopaedic implants
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New polymer could improve semiconductor manufacturing, packaging
New polymer could improve semiconductor manufacturing, packaging
(Date:12/2/2009)... Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion ... trial of Cotara® in patients with relapsed glioblastoma multiforme ... is a targeted monoclonal antibody linked to a radioisotope ... Cotara specifically targets cells at the center of ...
(Date:12/2/2009)... Pepscan Holding NV,the Netherlands based biotechnology company focusing on ... announced that it,has appointed Wim E.M. Mol, Ph.D. as ... Dr. Mol will be responsible for all of Pepscans ... the company. He brings to,Pepscan more than 20 years ...
(Date:12/2/2009)... today announced data presentations on its novel oral JAK2 ... Annual Meeting and Exposition in New Orleans. ,, Data ... Phase 1 dose-escalation trial of SB1518 detailing its safety, ... from 100 to 600 mg. These doses were administered ...
(Date:12/2/2009)... /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ... company focused on endocrine therapy and oncology, today ... (FDA) has granted Fast Track designation for the ... the treatment of relapsed/refractory multiple myeloma. Keryx Biopharmaceuticals, ...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
... gathered , if your PCR yields no product:, , , , , , , ... , , Non-optimal , ... , , The amount of , ... , , , ...
... , , , , , , , Here are ... , , , , , , ... , <a , ... , , , ...
... , Cat. No. 3 315 932, 25 ml (25 vials of 1 ml) ... , Cat. No. 3 315 843, 100 ml (4 vials of 25 ml)) , ... , , , Specially purified, double distilled, deionized, auto-claved water ... Routinely function checked in PCR pH at 20C: 8.3 , , , ...
Other Biology Technology:Trouble-shooting: No product 2Trouble-shooting: No product 3Trouble-shooting: No product 4Trouble-shooting: No product 5Trouble-shooting: Low yield 2Trouble-shooting: Low yield 3Trouble-shooting: Low yield 4Trouble-shooting: Low yield 5Trouble-shooting: Low yield 6Trouble-shooting: Low yield 7PCR Grade Water 2
(Date:12/3/2009)... change in warmer water, according to an intriguing new study ... , Experiments with two species of young damselfish on Australia,s ... some reef fish are either consistently timid, or consistently bold, ... water temperatures rise. , A slight lift of just one ...
(Date:12/3/2009)... to investment in energy efficient technologies research, but Engineering ... Delpy believes that more is needed: "Scientific and engineering ... and solar power solutions, but more investment is needed ... are to meet our carbon emission targets by 2020 ...
(Date:12/2/2009)... acculturated Latino men have a more difficult time quitting ... culture, but acculturation has no affect on Latinas odds ... in Cancer Epidemiology, Biomarkers & Prevention , a ... December issue has a special focus on tobacco. , ...
Breaking Biology News(10 mins):Fish with attitude: Some like it hot 2Research is vital to a cleaner, greener, low carbon future 2Acculturation affects smoking cessation success among Latinos 2DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 1DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 2DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 3DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 4American Society of Plastic Surgeons hosts 78th annual meeting 58275 1American Society of Plastic Surgeons hosts 78th annual meeting 58275 2American Society of Plastic Surgeons hosts 78th annual meeting 58275 3World Heart Day resonates with recent experts findings on CVD and EU institutions determination to promote heart health 58272 1World Heart Day resonates with recent experts findings on CVD and EU institutions determination to promote heart health 58272 2World Heart Day resonates with recent experts findings on CVD and EU institutions determination to promote heart health 58272 3
... sure-to-be-controversial new study, Emily Oster (a graduate student in ... such as infanticide, may not be the only cause ... Asian countries. It has long been observed that the ... countries than in the West, where it is close ...
... of York's Department of Chemistry have developed a gel ... and dangerous side-effects of radiotherapy. , PhD students Andrew ... Mark Godber, have developed the gel which will help ... the group has secured £30,000 under the Bioscience Yorkshire ...
... an increased risk of hypertension in women, although an ... diet colas, according to a study in the November ... in the United States have hypertension, and the prevalence ... Hypertension is a major risk factor for coronary heart ...
Other Biology News:Young scientists turn to gel to ease side-effects of cancer treatment 2No link found between caffeine intake and development of hypertension in women 2
... the Flp-In System creates isogenic cell ... levels of the protein of interest. ... Figure 3 (click link below). In ... chloramphenicol-acetyl transferase (CAT) was subcloned into ...
Growth Medium / Media...
...
Recombinant Rat Leptin, CF...
Biology Products: